Podcast: Strong Product Differentiation - - BioPharm International

ADVERTISEMENT

Podcast: Strong Product Differentiation


blog comments powered by Disqus


In this final podcast of three, Anjan Selz, cofounder and CEO of Finox Biotech, denounces the destructive nature of focusing only on price in the biosimilar space and states that the ability to differentiate and improve a product offering should be the driver for development. Selz notes that differentiation can come in many forms and include new formulations, the delivery device or even packaging. In the case of a "lifestyle" drug like Afolia, the emphasis is offering improved consumer experience. Selz concludes by offering excellent insight into project management and some of the secrets behind moving so quickly through development. Posted Jan. 2012.

Podcast 1 on biosimilar candidate choice and outsourcing

Podcast 2 on meeting regulatory expectations

ADVERTISEMENT

ADVERTISEMENT

First Biosimilar Application Kicks Off Legal Battle
October 31, 2014
FDA Approves Pfizer's Trumenba for the Prevention of Meningitis B
October 30, 2014
EMA: Extrapolation Across Indications for Biosimilars a Possibility
October 30, 2014
Bristol-Myers Squibb Announces Agreement to Acquire HER2-Targeted Cancer Treatment
October 29, 2014
Amgen, Sanofi, and Ono Pharmaceuticals Partner with Universities on Transmembrane Protein Research
October 28, 2014
Author Guidelines

Click here